COMMUNIQUÉS West-GlobeNewswire

Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’American Glaucoma Society (AGS)
10/02/2026
Communiqué de presse Nicox : Présentation des données des études de Phase 3 de NCX 470 au congrès annuel 2026 de l’ American Glaucoma Society (AGS) 10 février 2026 – publication à 7H30 Sophia Antipolis, France Nicox SA [...]
Santhera Appoints Stifel as Corporate Finance Advisor
10/02/2026
Pratteln, Switzerland, February 10, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced the appointment of Stifel Nicolaus Europe Limited (“Stifel”) as corporate finance advisor with a focus on capital markets [...]
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026
10/02/2026
Press Release Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026 February 10, 2026 – release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Growth Paris: [...]
Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day
10/02/2026
Amsterdam, February 10, 2026 Full year and Q4 highlights Comparable order intake growth 6% in 2025; up 7% in Q4 Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth 2% in 2025, 7% in [...]
Philips proposes to re-appoint CEO Roy Jakobs
10/02/2026
February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive [...]
Fangzhou ’XingShi’ Large Language Model Highlighted Among China’s Most Anticipated Healthcare Models for 2026
10/02/2026
SHANGHAI, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Industry research platform VBData recently highlighted “XingShi” Large Language Model (“XS LLM”) from Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI [...]
Restore Brain Highlights New Insights on How TMS Therapy Works Following Dallas Behavioral Health Summit
10/02/2026
Restore Brain executive John Cavanagh shared neuroscience-based insights on TMS during a recent behavioral health summit held in Dallas Restore Brain Logo DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Restore Brain, a multi [...]
Propr® Launches Propr Picks: Innovative Floss Picks to Elevate Daily Oral Care
10/02/2026
NEW YORK, NY, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Propr ®, the fluoride free oral care brand founded by acclaimed periodontist Dr. Jack Gruber , today announced the launch of Propr Picks , a thoughtfully engineered dental [...]
PetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ET
09/02/2026
MINNEAPOLIS, MN, US, Feb. 09, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering [...]
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
09/02/2026
BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certain business [...]
SafeSpace Global Corp. (OTCID: SSGC) Announces Investor Day to be held in Nashville, Tennessee on February 27, 2026
09/02/2026
Company to Meet with Investors and Financial Institutions During Event Knoxville, TN, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) ("SafeSpace" or the "Company"), a provider of [...]
Agomab Announces Closing of Initial Public Offering
09/02/2026
ANTWERP, Belgium, February 9, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology [...]
DLH Reports Fiscal 2026 First Quarter Results
09/02/2026
ATLANTA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
09/02/2026
Châtillon, France, February 9, 2025 DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “ [...]
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
09/02/2026
BOSTON, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]
Earth Science Tech, Inc. (ETST), to Report Financial Results for Fiscal Third Quarter on February 17, 2026
09/02/2026
MIAMI, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced [...]
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
09/02/2026
ALISO VIEJO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the closing of its initial public offering of 10, [...]
DBV Technologies participeà la conférence Emerging Outlook: Biotech Summit organisée par Guggenheim Securities
09/02/2026
Châtillon, France, le 9 février (22 :30 CET) 2026 DBV Technologies participeà la conférence Emerging Outlook: Biotech Summit organisée par Guggenheim Securities DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – [...]
LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026
09/02/2026
SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth quarter and full year 2025 [...]

Pages